Press Releases - Emmaus Medical, Inc.

Emmaus Life Sciences Announces Strategic TransactionDecember 30, 2025

Enters into North American License and Exclusive Distribution Agreement

Emmaus Life Sciences Reports Quarterly Financial ResultsNovember 14, 2025

Emmaus Life Sciences, Inc., today reported on its financial condition and results of operations as of and for the three months ended September 30, 2025.

Emmaus Life Sciences Reports Quarterly Financial ResultsAugust 14, 2025

Emmaus Life Sciences, Inc., today reported on its financial condition and results of operations as of and for the three and six months ended June 30, 2025.

Emmaus Life Sciences Receives FDA Approval for Endari® Label EnhancementsJune 26, 2025

Changes Based on Additional Pharmacokinetics Data

Emmaus Life Sciences Reports Quarterly Financial ResultsMay 15, 2025

Emmaus Life Sciences, Inc., today reported on its financial condition and results of operations as of and for the three months ended March 31, 2025.